chr12-1831136-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000382722.10(CACNA2D4):c.2551+9603T>G variant causes a intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
CACNA2D4
ENST00000382722.10 intron
ENST00000382722.10 intron
Scores
11
7
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
LRTM2 (HGNC:32443): (leucine rich repeats and transmembrane domains 2) Predicted to enable Roundabout binding activity and heparin binding activity. Predicted to be involved in axon guidance and negative chemotaxis. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39920378).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRTM2 | NM_001039029.3 | c.269A>C | p.Asn90Thr | missense_variant | 4/5 | ENST00000299194.6 | NP_001034118.1 | |
CACNA2D4 | NM_172364.5 | c.2551+9603T>G | intron_variant | ENST00000382722.10 | NP_758952.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRTM2 | ENST00000299194.6 | c.269A>C | p.Asn90Thr | missense_variant | 4/5 | 2 | NM_001039029.3 | ENSP00000299194.1 | ||
CACNA2D4 | ENST00000382722.10 | c.2551+9603T>G | intron_variant | 1 | NM_172364.5 | ENSP00000372169.4 | ||||
CACNA2D4 | ENST00000586184.5 | c.2551+9603T>G | intron_variant | 5 | ENSP00000465060.1 | |||||
CACNA2D4 | ENST00000587995.5 | c.2476+9603T>G | intron_variant | 5 | ENSP00000465372.1 | |||||
CACNA2D4 | ENST00000585708.5 | c.2359+9603T>G | intron_variant | 5 | ENSP00000467697.1 | |||||
CACNA2D4 | ENST00000588077.5 | c.2359+9603T>G | intron_variant | 5 | ENSP00000468530.1 | |||||
CACNA2D4 | ENST00000444595.6 | n.*797+9603T>G | intron_variant | 1 | ENSP00000403371.2 | |||||
CACNA2D4 | ENST00000537784.5 | n.391+9603T>G | intron_variant | 1 | ENSP00000440231.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.269A>C (p.N90T) alteration is located in exon 4 (coding exon 2) of the LRTM2 gene. This alteration results from a A to C substitution at nucleotide position 269, causing the asparagine (N) at amino acid position 90 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;L;L;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N;N;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
P;P;P;.;.
Vest4
MutPred
Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at